Singh Prabhat, Gupta Surbhi, Sharma Bhupesh
CNS and CVS Pharmacology Lab., Department of Pharmacology, School of Pharmacy, Bharat Institute of Technology, Partapur Bypass, Meerut, 250103 Uttar Pradesh, India.
School of Pharmacy, Bharat Institute of Technology, Partapur Bypass, Meerut, 250103 Uttar Pradesh, India; CNS Pharmacology, Conscience Research, Pocket F-233, B, Dilshad Garden, Delhi 110095, India.
Physiol Behav. 2015 Apr 1;142:66-78. doi: 10.1016/j.physbeh.2015.02.009. Epub 2015 Feb 7.
Cerebrovascular and cardiovascular diseases are stated as important risk factors of vascular dementia (VaD) and other cognitive disorders. In the central nervous system, melatonin (MT1/MT2) as well as serotonin subtype 2C (5-HT2C) receptors is pharmacologically associated with various neurological disorders. Brain mitochondrial potassium channels have been reported for their role in neuroprotection. This study has been structured to investigate the role of agomelatine, a melatonergic MT1/MT2 agonist and nicorandil, a selective ATP sensitive potassium (KATP) channel opener in renal artery ligation (two-kidney-one-clip: 2K1C) hypertension induced endothelial dysfunction, brain damage and VaD. 2K1C-renovascular hypertension has increased mean arterial blood pressure (MABP), impaired memory (elevated plus maze and Morris water maze), endothelial function, reduced serum nitrite/nitrate and increased brain damage (TTC staining of brain sections). Furthermore, 2K1C animals have shown high levels of oxidative stress in serum (increased thiobarbituric acid reactive species-TBARS with decreased levels of glutathione-GSH, superoxide dismutase-SOD and catalase-CAT), in the aorta (increased aortic superoxide anion) and in the brain (increased TBARS with decreased GSH, SOD and CAT). 2K1C has also induced a significant increase in brain inflammation (myeloperoxidase-MPO levels), acetylcholinesterase activity (AChE) and calcium levels. Impairment in mitochondrial complexes like NADH dehydrogenase (complex-I), succinate dehydrogenase (complex-II) and cytochrome oxidase (complex-IV) was also noted in 2K1C animals. Administration of agomelatine, nicorandil and donepezil significantly attenuated 2K1C-hypertension induced impairments in memory, endothelial function, nitrosative stress, mitochondrial dysfunction, inflammation and brain damage. Therefore, modulators of MT1/MT2 receptors and KATP channels may be considered as potential agents for the management of renovascular hypertension induced VaD.
脑血管疾病和心血管疾病被认为是血管性痴呆(VaD)和其他认知障碍的重要危险因素。在中枢神经系统中,褪黑素(MT1/MT2)以及血清素2C亚型(5-HT2C)受体在药理学上与多种神经系统疾病相关。脑线粒体钾通道因其在神经保护中的作用而被报道。本研究旨在探讨阿戈美拉汀(一种褪黑素能MT1/MT2激动剂)和尼可地尔(一种选择性ATP敏感性钾通道开放剂)在肾动脉结扎(两肾一夹:2K1C)高血压诱导的内皮功能障碍、脑损伤和VaD中的作用。2KIC肾血管性高血压使平均动脉血压(MABP)升高、记忆受损(高架十字迷宫和莫里斯水迷宫实验结果)、内皮功能受损、血清亚硝酸盐/硝酸盐水平降低以及脑损伤增加(脑切片TTC染色)。此外,2K1C动物在血清(硫代巴比妥酸反应性物质-TBARS增加,谷胱甘肽-GSH、超氧化物歧化酶-SOD和过氧化氢酶-CAT水平降低)、主动脉(主动脉超氧阴离子增加)和脑(TBARS增加,GSH、SOD和CAT降低)中表现出高水平的氧化应激。2K1C还导致脑炎症(髓过氧化物酶-MPO水平)、乙酰胆碱酯酶活性(AChE)和钙水平显著增加。在2K1C动物中还发现线粒体复合物如NADH脱氢酶(复合物I)、琥珀酸脱氢酶(复合物II)和细胞色素氧化酶(复合物IV)受损。给予阿戈美拉汀、尼可地尔和多奈哌齐可显著减轻2K1C高血压诱导的记忆、内皮功能、亚硝化应激、线粒体功能障碍、炎症和脑损伤。因此,MT1/MT2受体和KATP通道的调节剂可被视为治疗肾血管性高血压诱导的VaD的潜在药物。